Accessibility Menu
 
Physiomics Plc logo

Physiomics Plc

(LSE) PYC

Current Price$0.44
Market Cap$206.21M
Since IPO (2004)-100%
5 Year-94%
1 Year+6%
1 Month-13%

Physiomics Plc Financials at a Glance

Market Cap

$206.21M

Revenue (TTM)

$1.47M

Net Income (TTM)

$1.12M

EPS (TTM)

$-0.16

P/E Ratio

-2.84

Dividend

$0.00

Beta (Volatility)

0.06 (Low)

Price

$0.44

Volume

334,386

Open

$0.43

Previous Close

$0.44

Daily Range

$0.43 - $0.44

52-Week Range

$0.25 - $0.70

PYC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Physiomics Plc

Industry

Life Sciences Tools and Services

CEO

Peter Sargent, PhD

Headquarters

Oxford, OX4 4GA, GB

PYC Financials

Key Financial Metrics (TTM)

Gross Margin

-57%

Operating Margin

-57%

Net Income Margin

-51%

Return on Equity

-120%

Return on Capital

-1%

Return on Assets

-87%

Earnings Yield

-35.21%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$206.21M

Shares Outstanding

453.21M

Volume

334.39K

Short Interest

0.00%

Avg. Volume

7.98M

Financials (TTM)

Gross Profit

$435.08K

Operating Income

$457.79K

EBITDA

$448.21K

Operating Cash Flow

$546.14K

Capital Expenditure

$3.94K

Free Cash Flow

$550.08K

Cash & ST Invst.

$461.24K

Total Debt

$0.00

Physiomics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$498.00K

+30.4%

Gross Profit

$357.00K

-51.3%

Gross Margin

-71.69%

N/A

Market Cap

$206.21M

N/A

Market Cap/Employee

$18.75M

N/A

Employees

11

N/A

Net Income

$301.00K

-46.1%

EBITDA

$352.00K

-51.7%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$257.00K

-36.2%

Accounts Receivable

$288.00K

-24.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-86.96%

N/A

Return on Invested Capital

-1.38%

N/A

Free Cash Flow

$204.00K

+42.2%

Operating Cash Flow

$202.00K

+42.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TCF.LTheracryf Plc
$0.20+0.00%
VAL.LValiRx plc
$0.30+0.00%
POLX.LPolarean Imaging plc
$0.08-20.00%
TRLS.LTrellus Health plc
$0.17-22.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
INTCIntel
$48.03+0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NKENike
$44.63-0.16%

Questions About PYC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.